Correlation Between Achilles Therapeutics and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and CytomX Therapeutics, you can compare the effects of market volatilities on Achilles Therapeutics and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and CytomX Therapeutics.
Diversification Opportunities for Achilles Therapeutics and CytomX Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Achilles and CytomX is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and CytomX Therapeutics
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to under-perform the CytomX Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Achilles Therapeutics PLC is 2.75 times less risky than CytomX Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The CytomX Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 171.00 in CytomX Therapeutics on August 23, 2024 and sell it today you would lose (84.00) from holding CytomX Therapeutics or give up 49.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. CytomX Therapeutics
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| CytomX Therapeutics |
Achilles Therapeutics and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and CytomX Therapeutics
The main advantage of trading using opposite Achilles Therapeutics and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| CytomX Therapeutics vs. Kiora Pharmaceuticals | CytomX Therapeutics vs. ZyVersa Therapeutics | CytomX Therapeutics vs. Sonnet Biotherapeutics Holdings | CytomX Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |